Chipinduro 2017.
Study characteristics | |||
Patient Sampling | Cross‐sectional, manner of selection not reported, unknown | ||
Patient characteristics and setting | Presenting signs and symptoms: participants were children 5 to 16 years of age presenting with a chronic cough of 2 weeks and any of the classic signs and symptoms of TB, including weight loss, loss of appetite, persistent fever without an apparent cause, night sweats, or history of close contact with a TB index patient, defined as living in close proximity (sharing a room within a household) with an adult diagnosed with TB within the preceding 12 months Age, months: median 127 Sex, female: 56% HIV infection: 50% Sample size included for analysis: 218 Clinical setting: outpatient Laboratory level where index test was performed: not reported Country: Zimbabwe World Bank income classification: middle income High TB burden country: yes High TB/HIV burden country: yes High MDR‐TB burden country: yes Prevalence of tuberculosis cases in the study: 9% | ||
Index tests | Xpert MTB/RIF | ||
Target condition and reference standard(s) | Pulmonary tuberculosis Solid culture (LJ); composite reference standard; clinical reference standard |
||
Flow and timing | Index test and reference standard were collected within pre‐specified interval | ||
Comparative | |||
Notes | Study evaluated Xpert MTB/RIF in stool and induced sputum; no consensus has been reached on the proper stool processing method for Xpert; this study used centrifugation | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Could the selection of patients have introduced bias? | Low risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 2: Index Test (Xpert MTB/RIF) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Unclear | ||
DOMAIN 2: Index Test (Xpert Ultra) | |||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Unclear | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Unclear risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk |